Zobrazeno 1 - 10
of 1 566
pro vyhledávání: '"Somatostatin analogues"'
Diabetes mellitus in acromegaly: prevalence, pathophysiological particulars and treatment strategies
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 51, Iss 6, Pp 344-354 (2023)
The prevalence of diabetes mellitus in acromegaly is significantly higher than that in the general population. Carbohydrate metabolism abnormalities often precede other phenotypic manifestations of acromegaly. The review presents data on the prevalen
Externí odkaz:
https://doaj.org/article/16e53b523e38429183f494b632d99453
Autor:
Masclee GM, Masclee AA
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 16, Pp 197-211 (2023)
Gwen MC Masclee,1 Ad AM Masclee2,3 1Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands; 2Department of Gastroenterology and Hepatology, Maastricht University Medical Center +, Maastricht, th
Externí odkaz:
https://doaj.org/article/5a60ca55f03545459a8afaae50d5e23a
Autor:
Abdulhameed Alfagih, Abdulaziz AlJassim, Nasser Alqahtani, Michael Vickers, Rachel Goodwin, Timothy Asmis
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7508-7519 (2023)
(1) Aim: The prevalence and incidence of small bowel NETs have increased significantly over the past two decades. This study aims to report the 10-year experience of SB-NET management at a regional cancer center in Canada. (2) Materials and methods:
Externí odkaz:
https://doaj.org/article/5191ab6f226346e8893b62ff500e151a
Autor:
Claus von Hessert-Vaudoncourt, Sara Lelek, Christina Geisler, Teresa Hartung, Vanessa Bröker, Franziska Briest, Liliana Mochmann, Fabian Jost-Brinkmann, Dagmar Sedding, Joana Benecke, Helma Freitag, Sebastian Wolfshöfer, Hedwig Lammert, Svenja Nölting, Michael Hummel, Jörg Schrader, Patricia Grabowski
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Somatostatin analogues (SSAs) are commonly used in the treatment of hormone hypersecretion in neuroendocrine tumors (NETs), however the extent to which they inhibit proliferation is much discussed.Objective: We studied the antiprolifera
Externí odkaz:
https://doaj.org/article/a407b702dbba487e9691d99b0851500c
Autor:
L. K. Dzeranova, M. I. Yevloyeva, M. A. Perepelova, E. A. Pigarova, A. S. Shutova, A. V. Dorovskikh, V. N. Azizyan, E. G. Przhiyalkovskaya
Publikováno v:
Ожирение и метаболизм, Vol 20, Iss 1, Pp 66-72 (2023)
Acromegaly is a severe neuroendocrine disease characterized by hypersecretion of growth hormone (GH) caused in 95% of cases by pituitary adenoma, which leads to the development of pathology of various organs and systems. The severity of the condition
Externí odkaz:
https://doaj.org/article/ad0f04113fc14f3b918d8d28dea9a6b5
The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
Autor:
Aldona Kasprzak, Agnieszka Geltz
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 578 (2024)
Somatostatin, a somatotropin release inhibiting factor (SST, SRIF), is a widely distributed multifunctional cyclic peptide and acts through a transmembrane G protein-coupled receptor (SST1-SST5). Over the past decades, research has begun to reveal th
Externí odkaz:
https://doaj.org/article/85ae09a841bb41b49553334817f19cbc
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/e751b1b08e2c40b9b1f32f4ef6765086
Autor:
Rihards Saksis, Olesja Rogoza, Helvijs Niedra, Kaspars Megnis, Ilona Mandrika, Inga Balcere, Liva Steina, Janis Stukens, Austra Breiksa, Jurijs Nazarovs, Jelizaveta Sokolovska, Ilze Konrade, Raitis Peculis, Vita Rovite
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-21 (2023)
Abstract Pituitary neuroendocrine tumours (PitNETs) are neoplasms of the pituitary that overproduce hormones or cause unspecific symptoms due to mass effect. Growth hormone overproducing GH-producing PitNETs cause acromegaly leading to connective tis
Externí odkaz:
https://doaj.org/article/29d030e8136840839256602be7185efa
Publikováno v:
Livers, Vol 2, Iss 4, Pp 315-335 (2022)
Patients with advanced hepatocellular carcinoma (HCC) have a very limited survival rate even after the recent inclusion of kinase inhibitors or immune checkpoint inhibitors in the therapeutic armamentarium. A significant problem with the current prop
Externí odkaz:
https://doaj.org/article/400b49a46758479d9d62f26c31a9926a
Autor:
Á.N. Del Cueto-Aguilera, D. García-Compeán, A.R. Jiménez-Rodríguez, O.D. Borjas-Almaguer, M.I. Wah-Suárez, J.A. González-González, H.J. Maldonado-Garza
Publikováno v:
Revista de Gastroenterología de México, Vol 87, Iss 4, Pp 411-419 (2022)
Resumen: Introducción: El 50% de las hemorragias del intestino delgado son causadas por angiectasias del intestino delgado (AID) y la tasa de recurrencia es del 80%. Su tratamiento endoscópico es difícil. Algunos estudios han informado efectos ben
Externí odkaz:
https://doaj.org/article/7314c89cd9a44484ad4840ac47bc190f